Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm
Description GHK-Cu is a synthetic copper-binding tripeptide (Copper Tripeptide-1) supplied as a lyophilized research material for in vitro and analytical laboratory applications
Side effects during month one remain manageable for most users
They target different receptor systems (GHRH receptors versus GLP-1 receptors), are metabolized independently, and don't compete for binding sites or enzymes
Avoid injecting into broken skin, scar tissue, bruised or infected areas, moles, or sites showing signs of lipohypertrophy
Bundle with other beauty or detox products for increased value
US$ 23.43
US$ 26.54
US$ 25.68
US$ 23.57
US$ 21.35
US$ 20.56
